{{Rsnum
|rsid=4704970
|Chromosome=5
|position=156073982
|Orientation=plus
|GMAF=0.1107
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=SGCD
|Gene_s=SGCD
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 28.3 | 66.4
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 7.5 | 92.5
| ASW | 1.8 | 12.3 | 86.0
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 1.0 | 22.8 | 76.2
| LWK | 2.8 | 16.7 | 80.6
| MEX | 1.7 | 19.0 | 79.3
| MKK | 0.0 | 13.5 | 86.5
| TSI | 2.0 | 35.3 | 62.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs4704970
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 5q33.2; Reported Gene(s): SGCD; Risk Allele: rs4704970-?); (p-value= 0.000007).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740720
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4704970
|overall_frequency_n=18
|overall_frequency_d=128
|overall_frequency=0.140625
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}